Delivery Order SPE2DB20D9135-SPE2DB23FZW48

Award Date 6/8/23
Potential Completion Date 6/30/23
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $53,318.24 and is set to expire on September 7, 2023. DMS Pharmaceutical Group Inc. will provide 4,562,306,477 MACI 3CM X 5CM IMPLANT SHEETS to support the recurring medical supply needs of military health facilities. This delivery order is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,902.91 contract is for the delivery of 4567967727 MACI 3CM X 5CM IMPLANT SHEETS and has a period of performance through March 31, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, with a period of performance through June 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product, with an ultimate completion date of October 1, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a $61,902.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS and has an ultimate completion date of February 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $57,317.20 contract is for the delivery of 4565835336 MACI 3CM X 5CM implant sheets and has an ultimate completion date of August 29, 2024. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 contract is for the supply of 4563201038 MACI 3CM X 5CM IMPLANT SHEETS, with a period of performance through November 24, 2023. DMS Pharmaceutical Group holds a single-award, indefinite-delivery contract (IDC) valued at up to $499,999,999 with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $61,902.90, is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, a type of specialized medical implant. The contract has an ultimate completion date of January 6, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $57,317.20 contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $53,318.24 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS to fulfill the recurring pharmaceutical and medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB23FZW48
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $53,318.24, is for the provision of MACI 3CM X 5CM IMPLANT SHEETS and has a period of performance through June 30, 2023.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is issued under this larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:08 AM